Melinta Therapeutics

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Melinta Therapeutics funding round, January 2009
25,000,000
January 25, 2009
Axiom Ventures
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Nick Paul
June 5, 2020
FierceBiotech
Melinta Therapeutics has struck a deal to buy Tetraphase Pharmaceuticals. The deal, which follows a bidding war with AcelRx Pharmaceuticals, gives Melinta another approved product and potentially complementary R&D expertise to support its bid to bounce back from bankruptcy.
June 4, 2020
BioSpace
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals - read this article along with other careers information, tips and advice on BioSpace
BioSpace
December 27, 2019
BioSpace
Company Initiates Voluntary Chapter 11 Process to Effectuate Restructuring Transaction While Continuing Normal-Course Operations
February 13, 2020
BioSpace
Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures - read this article along with other careers information, tips and advice on BioSpace
Andrew Jacobs
December 25, 2019
www.nytimes.com
First Big Pharma fled the field, and now start-ups are going belly up, threatening to stifle the development of new drugs.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.